Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Income Tax (Tables)

v3.20.1
Income Tax (Tables)
 12 Months Ended
Dec. 31, 2019
Major components of tax expense (income) [abstract]  
Schedule of deferred income taxes

    As of December 31,  
    2019     2018  
In respect of:            
Net operating loss carry forward   $ 12,607     $ 10,170  
Research and development expenses     801       753  
Less – valuation allowance     (13,408 )     (10,923 )
Net deferred tax assets   $ -     $ -  
Schedule of valuation allowance

Balance at January 1, 2017   $ 9,051  
Additions     2,104  
Balance at December 31, 2017   $ 11,155  
Additions     (232 )
Balance at December 31, 2018   $ 10,923  
Additions     2,485  
Balance at December 31, 2019   $ 13,408